Can an AI match expert doctors at spotting troubled babies during labor?

NCT ID NCT07827222

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

During labor, doctors watch fetal heart rate and contraction tracings to spot signs of oxygen trouble, but different clinicians often read the same tracing differently. This study tests whether the AI model Gemini Flash 3.6 can classify the final hour of tracings from 415 laboring women into FIGO categories of Normal, Suspicious, or Pathological, and compares its accuracy with three expert obstetricians. The AI's readings stay in research hands and never guide patient care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Gemini Flash 3.6, an artificial intelligence model that reads cardiotocography tracings
What this could lead to
If the AI reads tracings as well as experts, it could offer a consistent second opinion during labor and reduce disagreement between clinicians.
What could go wrong
This is a single-center diagnostic accuracy study, so a good result would not prove the AI improves outcomes in real deliveries. The model never guides care here, and it may miss cases that experts catch.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 415 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women admitted in active labor at term (gestational age 37+0 weeks or greater) with singleton pregnancies in cephalic presentation undergoing routine continuous intrapartum cardiotocography (CTG) monitoring at Abutig Specialized Hospital and Women's Health Hospital, Assiut University, Egypt.

Ages

18 years and older

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Singleton pregnancy * Gestational age 37+0 weeks or greater * Cephalic fetal presentation * Admission to the labor ward in active labor * Continuous intrapartum cardiotocography (CTG) monitoring * Availability of an interpretable CTG tracing immediately preceding delivery * Availability of documented 1-minute and 5-minute Apgar scores * Written informed consent obtained prior to enrollment Exclusion Criteria: * Multiple pregnancy * Major fetal congenital anomalies * Antepartum stillbirth * Elective cesarean delivery performed before the onset of labor without an adequate intrapartum CTG tracing * CTG tracing with inadequate technical quality, including signal loss of 15% or greater * Missing 5-minute Apgar score * Technical problems preventing standardized CTG image preparation or interpretation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal distress are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fetal Distress Fetal Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.